Modulation of the pro-inflammatory molecules E-selectin and TNF-α gene transcription in Eimeria ninakohlyakimovae -infected primary caprine host endothelial cells

2015 ◽  
Vol 64 (5) ◽  
pp. 471-477 ◽  
Author(s):  
D. Pérez ◽  
A. Ruiz ◽  
M.C. Muñoz ◽  
J.M. Molina ◽  
C. Hermosilla ◽  
...  
Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Sachiko Nishimoto ◽  
Daiju Fukuda ◽  
Yasutomi Higashikuni ◽  
Kimie Tanaka ◽  
Yoichiro Hirata ◽  
...  

Background: Peripheral artery disease causes significant functional disability and results in impaired quality of life. Toll-like receptor (TLR)-2, 3 and 4 are suggested to participate in blood flow recovery in ischemic limb by modulating inflammation and angiogenesis, however, the role of TLR9 remains unknown. TLR9 recognizes bacterial unmethylated DNA and plays a role in innate defense, although it can also provoke inflammation in response to fragmented DNA released from regenerated mammalian cells. This study tested the hypothesis that genetic deletion of TLR9 accelerates blood flow recovery after femoral artery ligation by inhibiting inflammation and improving endothelial cell function. Methods and Results: Unilateral femoral artery ligation was performed in TLR9-deficient (TLR9KO) mice and wild type (WT) mice. Femoral artery ligation significantly increased RNA expression of TLR9 (20-times) in WT mice and plasma levels of single-stranded DNA and double-stranded DNA, endogenous ligands for TLR9, in both strains of mice compared with each sham-operated group (P<0.05). Laser Doppler perfusion imaging demonstrated that TLR9KO mice significantly improved the ratio of the blood flow in the ischemic to non-ischemic limb compared with WT mice at 2 weeks after ligation (P<0.05). TLR9KO mice showed less accumulation of macrophages and less expression of inflammatory molecules (e.g., TNF-α, MCP-1 and IL-1β in ischemic muscle compared with WT mice (P<0.05, respectively). In vitro experiments using thioglycolate-stimulated peritoneal macrophages demonstrated that CpG ODN, agonistic oligonucleotide for TLR9, promoted the expression of pro-inflammatory molecules (e.g., MCP-1 and TNF-α) in WT macrophages (P<0.05, respectively) but not in TLR9 KO macrophages. Furthermore, activation of TLR9 by CpG ODN inhibited migration and proliferation of endothelial cells as determined by scratch-wound assay and MTS assay, respectively (P<0.05). Conclusion: Our results suggested that TLR9 enhances inflammation and affects migration and proliferation of endothelial cells, leading to impaired blood flow recovery in ischemic limb. TLR9 may serve as a potential therapeutic target for ischemic limb disease.


2000 ◽  
Vol 279 (4) ◽  
pp. C906-C914 ◽  
Author(s):  
Arshad Rahman ◽  
Khandaker N. Anwar ◽  
Asrar B. Malik

We addressed the role of protein kinase C (PKC) isozymes in mediating tumor necrosis factor-α (TNF-α)-induced oxidant generation in endothelial cells, a requirement for nuclear factor-κB (NF-κB) activation and intercellular adhesion molecule-1 (ICAM-1) gene transcription. Depletion of the conventional (c) and novel (n) PKC isozymes following 24 h exposure of human pulmonary artery endothelial (HPAE) cells with the phorbol ester, phorbol 12-myristate 13-acetate (500 nM), failed to prevent TNF-α-induced oxidant generation. In contrast, inhibition of PKC-ζ synthesis by the antisense oligonucleotide prevented the oxidant generation following the TNF-α stimulation. We observed that PKC-ζ also induced the TNF-α-induced NF-κB binding to the ICAM-1 promoter and the resultant ICAM-1 gene transcription. We showed that expression of the dominant negative mutant of PKC-ζ prevented the TNF-α-induced ICAM-1 promoter activity, whereas overexpression of the wild-type PKC-ζ augmented the response. These data imply a critical role for the PKC-ζ isozyme in regulating TNF-α-induced oxidant generation and in signaling the activation of NF-κB and ICAM-1 transcription in endothelial cells.


2021 ◽  
Vol 220 ◽  
pp. 108034
Author(s):  
D. Pérez ◽  
T. Muñoz-Caro ◽  
L.M.R. Silva ◽  
M.C. Muñoz ◽  
J.M. Molina ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 2133-2133
Author(s):  
Tatiana M. Sakamoto ◽  
Carolina Lanaro ◽  
Vanessa Tonin Garrido ◽  
Margareth C. Ozelo ◽  
Sara T. Olalla-Saad ◽  
...  

Abstract Abstract 2133 The endothelium plays an important role in the pathophysiology of sickle cell anemia (SCA) due to interactions of endothelial cells with other cell types in the vaso-occlusive process and endothelial dysfunction caused by chronic inflammation and decreased nitric oxide bioavailability. Inflammatory molecules, such as cytokine TNF-α, may alter the endothelial cell surface and, thus, modulate the adhesion molecules that bind red blood cells (RBC). Damaged or activated endothelium produces cytokines and chemokines that result in the high levels of circulating inflammatory molecules found in the SCA. Blood Outgrowth Endothelial Cells (BOEC) are circulating endothelial cells isolated from the peripheral blood of adults, they have a high proliferative capacity in vitro, with the characteristic phenotype of mature cells. BOEC cultures were established to serve as a model for an in vitro study of endothelial properties and function in SCA, to evaluate RBC adhesion, expression of adhesion molecules and production of inflammatory cytokines in BOEC from healthy controls (Con) and SCA patients. Three cultures of BOEC from Con and three cultures from SCA patients in steady state were established and identification confirmed by flow cytometry (CD31+; CD146+; VEGF R2+; CD45-; CD133-). BOEC were used under basal conditions or following treatment with 10ng/ml TNF-α (3 H). RBC were isolated from Con, SCA and SCA patients on hydroxyurea treatment (SCAHU; 20–30 mg/Kg/day) and their adhesion to confluent Con and SCA BOEC was evaluated (4×106 cell/ml in EGM-2), using static adhesion assays. BOEC expression of adhesion molecules VCAM-1, E-selectin, P-selectin, CD36, the Vitronectin receptor and BCAM/Lu was evaluated by flow cytometry. The production and release of GM-CSF and IL-8 to the supernatant of BOEC in the presence and absence of an antiinflammatory stimulus (1μM Simvastatin, 3.5H) was quantified by ELISA. Notably, Con RBC adhered significantly more to SCA BOEC (16.6 ± 4.6%; n=14; p<0.001; Wilcoxon Test) than to Con BOEC (9.4 ± 3.2%; n=14). Furthermore, TNF-α stimulation further increased the adhesion of Con RBC to both Con BOEC (16.6 ± 5.6%; n=14 p<0.001 comp. to non-stimulated Con BOEC) and SCA BOEC (20.6 ±7.0%; n=14; p<0.05 comp. to non-stimulated SCA BOEC). Similarly, SCA RBC adhered significantly more to SCA BOEC (18.5 ± 4.8%; n=10; p<0.001; Wilcoxon Test) than to Con BOEC (14.3 ± 4.2%; n=10) and TNF-α stimulation further increased SCA RBC adhesion to Con BOEC (18.3 ± 5.4%; n=10; p<0.01) and SCA BOEC (20.9 ± 6.4%; n=10; p<0.05; Wilcoxon). SCAHU RBC also adhered more to SCA BOEC (19.5 ± 7.4%; p<0.01; Wilcoxon) compared to Con BOEC (14.3 ± 4.2%; n=10) and to TNF-α stimulated Con BOEC (19.1 ± 6.0%; n=10; p<0.01) and SCA BOEC (23.8 ± 6.3%; n=10; p<0.01), compared to respective non-stimulated BOEC. Con and SCA BOEC presented low-level expression of the P-selectin and CD36 adhesion molecules, even following TNF-α inflammatory stimulus; VCAM-1 was increased on both Con and SCA BOEC under TNF-α conditions, but no difference in expression was observed between the Con and SCA BOEC (data not shown); however, after TNF-α stimulus the expression of E-selectin on SCA BOEC was significantly higher (6613 ± 729 MFI; n=3; p=0.03; Unpaired t Test) than on Con BOEC (3645 ± 547 MFI; n=3). Vitronectin receptor and BCAM/Lu expression was slightly higher on SCA BOEC (6248.3 ± 552.9MFI; 1152 ± 51.4MFI respect; n=3; p<0.05, Unpaired t Test) than on Con BOEC (5059.7 ± 426.2MFI; 904.7 ± 70.9MFI; respect; n=3). Following TNF-α stimulus, SCA BOEC released significantly more GM-CSF (271.5 ± 8.7pg/ml; n=3; p<0.01; Unpaired t Test) than Con BOEC (175.2 ± 18.4pg/ml; n=3); where co-incubation with Simvastatin reduced the release of GM-CSF from TNF-α stimulated SCA (189.0 ± 7.1pg/ml; n=3; p<0.05 comp. to TNF-α SCA BOEC; Paired t Test) and Con BOEC (118.9 ± 21.9pg/ml; p<0.01; Paired t Test). SCA BOEC released more IL-8 (10977.4 ± 379.7pg/ml) than BOEC Con (8913.7 ± 234.7pg/ml) under TNF-α inflammatory conditions; however Simvastatin reduced the production of IL-8 only from Con BOEC (data not shown). Results suggest that SCA BOEC present inherent endothelial abnormalities that promote increased adhesion of red cells and augmented inflammatory properties, which are maintained during in vitro culture and following inflammatory stimulus. These cells may serve as a model for in vitro study of aberrant endothelial function in SCA. Support by FAPESP and CNPq Disclosures: No relevant conflicts of interest to declare.


2020 ◽  
Vol 90 (1-2) ◽  
pp. 103-112 ◽  
Author(s):  
Michael J. Haas ◽  
Marilu Jurado-Flores ◽  
Ramadan Hammoud ◽  
Victoria Feng ◽  
Krista Gonzales ◽  
...  

Abstract. Inflammatory and oxidative stress in endothelial cells are implicated in the pathogenesis of premature atherosclerosis in diabetes. To determine whether high-dextrose concentrations induce the expression of pro-inflammatory cytokines, human coronary artery endothelial cells (HCAEC) were exposed to either 5.5 or 27.5 mM dextrose for 24-hours and interleukin-1β (IL-1β), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor α (TNF α) levels were measured by enzyme immunoassays. To determine the effect of antioxidants on inflammatory cytokine secretion, cells were also treated with α-tocopherol, ascorbic acid, and the glutathione peroxidase mimetic ebselen. Only the concentration of IL-1β in culture media from cells exposed to 27.5 mM dextrose increased relative to cells maintained in 5.5 mM dextrose. Treatment with α-tocopherol (10, 100, and 1,000 μM) and ascorbic acid (15, 150, and 1,500 μM) at the same time that the dextrose was added reduced IL-1β, IL-6, and IL-8 levels in culture media from cells maintained at 5.5 mM dextrose but had no effect on IL-1β, IL-6, and IL-8 levels in cells exposed to 27.5 mM dextrose. However, ebselen treatment reduced IL-1β, IL-6, and IL-8 levels in cells maintained in either 5.5 or 27.5 mM dextrose. IL-2 and TNF α concentrations in culture media were below the limit of detection under all experimental conditions studied suggesting that these cells may not synthesize detectable quantities of these cytokines. These results suggest that dextrose at certain concentrations may increase IL-1β levels and that antioxidants have differential effects on suppressing the secretion of pro-inflammatory cytokines in HCAEC.


2000 ◽  
Vol 279 (3) ◽  
pp. H939-H945 ◽  
Author(s):  
Shareef Mustapha ◽  
Alla Kirshner ◽  
Danielle De Moissac ◽  
Lorrie A. Kirshenbaum

Nuclear factor-κB (NF-κB) is a ubiquitously expressed cellular factor regulated by the cytoplasmic factor inhibitor protein κBα (IκBα). Activation of NF-κB by cytokines, including tumor necrosis factor-α (TNF-α), requires the phosphorylation and degradation of IκBα. An anti-apoptotic role for NF-κB has recently been suggested. In the present study, we ascertained whether death-promoting signals and apoptosis mediated by TNF-α are suppressed by NF-κB in postnatal ventricular myocytes. Stimulation of myocytes with TNF-α resulted in a 12.1-fold increase ( P < 0.01) in NF-κB-dependent gene transcription and DNA binding compared with controls. This was accompanied by a corresponding increase in the NF-κB target protein A20 as determined by Western blot analysis. Vital staining revealed that TNF-α was not cytotoxic to myocytes and did not provoke apoptosis. Adenovirus-mediated delivery of a nonphosphorylatable form of IκBα to inactivate NF-κB prevented TNF-α-stimulated NF-κB-dependent gene transcription and nuclear NF-κB DNA binding. Importantly, myocytes stimulated with TNF-α and defective for NF-κB activation resulted in a 2.2-fold increase ( P < 0.001) in apoptosis. To our knowledge, the data provide the first indication that a functional NF-κB signaling pathway is crucial for suppressing death-promoting signals mediated by TNF-α in ventricular myocytes.


Nanomaterials ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 1247
Author(s):  
Sarah Belperain ◽  
Zi Yae Kang ◽  
Andrew Dunphy ◽  
Brandon Priebe ◽  
Norman H. L. Chiu ◽  
...  

Cardiovascular disease (CVD) has become an increasingly important topic in the field of medical research due to the steadily increasing rates of mortality caused by this disease. With recent advancements in nanotechnology, a push for new, novel treatments for CVD utilizing these new materials has begun. Carbon Nanodots (CNDs), are a new form of nanoparticles that have been coveted due to the green synthesis method, biocompatibility, fluorescent capabilities and potential anti-antioxidant properties. With much research pouring into CNDs being used as bioimaging and drug delivery tools, few studies have been completed on their anti-inflammatory potential, especially in the cardiovascular system. CVD begins initially by endothelial cell inflammation. The cause of this inflammation can come from many sources; one being tumor necrosis factor (TNF-α), which can not only trigger inflammation but prolong its existence by causing a storm of pro-inflammatory cytokines. This study investigated the ability of CNDs to attenuate TNF-α induced inflammation in human microvascular endothelial cells (HMEC-1). Results show that CNDs at non-cytotoxic concentrations reduce the expression of pro-inflammatory genes, mainly Interleukin-8 (IL-8), and interleukin 1 beta (IL-1β). The uptake of CNDs by HMEC-1s was examined. Results from the studies involving channel blockers and endocytosis disruptors suggest that uptake takes place by endocytosis. These findings provide insights on the interaction CNDs and endothelial cells undergoing TNF-α induced cellular inflammation.


Sign in / Sign up

Export Citation Format

Share Document